Matthew Campobasso - 26 Feb 2025 Form 4 Insider Report for Enfusion, Inc.

Role
General Counsel
Signature
/s/ Matthew Campobasso
Issuer symbol
N/A
Transactions as of
26 Feb 2025
Net transactions value
$0
Form type
4
Filing time
28 Feb 2025, 16:06:08 UTC
Previous filing
10 Jan 2025
Next filing
05 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +17,637 +33% $0.000000 70,288 26 Feb 2025 Direct F1
transaction ENFN Class A Common Stock Award $0 +3,434 +4.9% $0.000000 73,722 26 Feb 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full as follows: 5,879, 5,879 and 5,879 on each of February 26, 2026, 2027 and 2028.
F2 Consists of fully vested shares issued under the Plan.